AU2001269575A1 - Nucleic acid sequences and proteins involved in cellular senescence - Google Patents

Nucleic acid sequences and proteins involved in cellular senescence

Info

Publication number
AU2001269575A1
AU2001269575A1 AU2001269575A AU6957501A AU2001269575A1 AU 2001269575 A1 AU2001269575 A1 AU 2001269575A1 AU 2001269575 A AU2001269575 A AU 2001269575A AU 6957501 A AU6957501 A AU 6957501A AU 2001269575 A1 AU2001269575 A1 AU 2001269575A1
Authority
AU
Australia
Prior art keywords
nucleic acid
acid sequences
proteins involved
cellular senescence
senescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269575A
Inventor
Kyung-A Cho
Deok-In Kim
Jeong-Soo Park
Sang-Chul Park
Woong-Yang Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolic Engineering Laboratories Co Ltd
Original Assignee
Metabolic Engineering Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2000-0053342A external-priority patent/KR100489188B1/en
Priority claimed from KR10-2000-0053341A external-priority patent/KR100460190B1/en
Application filed by Metabolic Engineering Laboratories Co Ltd filed Critical Metabolic Engineering Laboratories Co Ltd
Publication of AU2001269575A1 publication Critical patent/AU2001269575A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

The present invention relates to nucleic acid sequences and proteins involved in senescence and particularly, to nucleic acid sequences and proteins including amphiphysin and caveolin involved in cellular senescence and their use.
AU2001269575A 2000-09-08 2001-07-06 Nucleic acid sequences and proteins involved in cellular senescence Abandoned AU2001269575A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR0000533 2000-09-08
KR10-2000-0053342A KR100489188B1 (en) 2000-09-08 2000-09-08 A Method for Detecting Senescent Cells, a Compostion for Inducing a Senescent State of Cells and a Method for Inducing a Senescent State of Cells Using Caveolin
KR10-2000-0053341A KR100460190B1 (en) 2000-09-08 2000-09-08 A Method for Detecting Senescent Cell, a Compostion for Restoring a Physiological Function of Senescent Cell and a Method for Restoring a Physiological Function of Senescent Cell Using Amphiphysin
PCT/KR2001/001159 WO2002021140A1 (en) 2000-09-08 2001-07-06 Nucleic acid sequences and proteins involved in cellular senescence

Publications (1)

Publication Number Publication Date
AU2001269575A1 true AU2001269575A1 (en) 2002-03-22

Family

ID=26638378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269575A Abandoned AU2001269575A1 (en) 2000-09-08 2001-07-06 Nucleic acid sequences and proteins involved in cellular senescence

Country Status (8)

Country Link
US (1) US7001769B2 (en)
EP (1) EP1315970B1 (en)
JP (1) JP3771218B2 (en)
CN (1) CN1460181A (en)
AT (1) ATE461453T1 (en)
AU (1) AU2001269575A1 (en)
DE (1) DE60141588D1 (en)
WO (1) WO2002021140A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100489188B1 (en) * 2000-09-08 2005-05-17 재단법인서울대학교산학협력재단 A Method for Detecting Senescent Cells, a Compostion for Inducing a Senescent State of Cells and a Method for Inducing a Senescent State of Cells Using Caveolin
KR100460190B1 (en) * 2000-09-08 2004-12-04 재단법인서울대학교산학협력재단 A Method for Detecting Senescent Cell, a Compostion for Restoring a Physiological Function of Senescent Cell and a Method for Restoring a Physiological Function of Senescent Cell Using Amphiphysin
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
KR100614523B1 (en) * 2003-07-24 2006-08-22 재단법인서울대학교산학협력재단 Methods for Restoring Biological Functions of Senescent Cells
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
EP1998794A4 (en) * 2006-03-24 2011-05-18 Gencia Corp Synthetic lipid rafts and methods of use
KR100896998B1 (en) * 2007-05-15 2009-05-14 재단법인서울대학교산학협력재단 A Composition for Regulating Cellular Senescence Comprising ???2??Cyclohexyloxyl??4?nitrophenyl]?methanesulfonamide
PT2750768T (en) 2011-08-30 2018-12-19 Astex Pharmaceuticals Inc Decitabine derivative formulations
WO2015048665A2 (en) * 2013-09-27 2015-04-02 The Regents Of The University Of California Method to estimate the age of tissues and cell types based on epigenetic markers
BR112018000054A2 (en) 2015-07-02 2018-09-04 Otsuka Pharmaceutical Co., Ltd. lyophilized pharmaceutical compositions
WO2019025863A2 (en) 2017-08-03 2019-02-07 Otsuka Pharmaceutical Co., Ltd. Drug compound and purification methods thereof
CN107496432A (en) * 2017-08-08 2017-12-22 拜尔思路生物科技（北京）有限公司 A kind of method by suppressing caveolin delaying cell aging
CN111366736A (en) * 2020-03-31 2020-07-03 中国科学院昆明动物研究所 Serum protein marker for indicating healthy aging key pathway and application thereof
CN112725437B (en) * 2021-02-02 2022-12-06 暨南大学 Application of rhythm gene protein expression and RNA methylation modification in preparation of aging detection kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US20020197602A1 (en) 1998-04-15 2002-12-26 Glenna C. Burmer Nucleic acid sequences and proteins associated with aging
AU7987800A (en) 1999-09-29 2001-04-30 Lifespan Biosciences, Inc. Anti-aging nucleic acid and protein targets

Also Published As

Publication number Publication date
EP1315970B1 (en) 2010-03-17
US7001769B2 (en) 2006-02-21
DE60141588D1 (en) 2010-04-29
US20050261265A1 (en) 2005-11-24
JP2004508031A (en) 2004-03-18
CN1460181A (en) 2003-12-03
JP3771218B2 (en) 2006-04-26
ATE461453T1 (en) 2010-04-15
EP1315970A1 (en) 2003-06-04
WO2002021140A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001251063A1 (en) 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
BR0215405A (en) Compositions and processes of use of collajolie
EP1660638A4 (en) Lipoparticles comprising proteins, methods of making, and using the same
AU2002317910A1 (en) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
IT1319241B1 (en) DECORATIVE OBJECT, IN PARTICULAR OF JEWELERY.
AU2001269575A1 (en) Nucleic acid sequences and proteins involved in cellular senescence
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
WO2002026968A3 (en) Antisense iap nucleic acids and uses thereof
DE60120712D1 (en) Kallikrein gen
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
AU2001238212A1 (en) Modified fluorescent proteins
AU2002314181A1 (en) Novel endothelially expressed dnas and proteins, and their use
AU2001293948A1 (en) Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
AU2001294833A1 (en) Chlamydia pmp proteins, gene sequences and uses thereof
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2002220697A1 (en) Isolated luciferases lu164, lual and lu22, and the use of the same
HK1050896A1 (en) Amino acid derivatives and use thereof as nep, aceand ece inhibitors.
WO2001053352A3 (en) Sperm specific proteins
EP1174469A3 (en) Linear polydialkylorganosiloxanes having polyoxyalkylene- and amino-functional groups, and also terminal alkoxy groups
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2001238091A1 (en) Tgf-beta therapeutics, compositions and methods of use
EP1501870A4 (en) Rsv proteins, antibodies, compositions, methods and uses
WO2005057486A3 (en) Protein engineering with analogous contact environments